Iodura De Potasiu Atb

Potassium Iodide, the active ingredient in Iodura De Potasiu Atb, is a thyroid blocking agent presented as an oral preparation for oral use. It supplies stable iodide that saturates the thyroid, limiting uptake of radioactive iodine and helping prevent iodine deficiency in at‑risk groups. It is included in emergency radiological response plans.

GNH USA supplies Iodura De Potasiu Atb as a licensed, GDP‑compliant supplier to hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, ensuring quality assurance, regulatory compliance and timely delivery across international markets.

Potassium Iodide is used as a thyroid blocking agent to reduce radioactive iodine uptake and to address iodine deficiency. - Radiation emergency: provides thyroid protection against radioactive iodine exposure. - Iodine deficiency prevention: supplies stable iodide to help maintain adequate iodine levels. - Pre‑treatment for radioactive iodine therapy: reduces thyroid uptake before diagnostic or therapeutic iodine procedures.

Potassium Iodide may cause a range of adverse reactions, most of which are mild and transient. Common Side Effects: - Metallic taste: a transient metallic sensation in the mouth that usually resolves quickly. - Nausea: mild nausea that may occur shortly after taking the dose. - Abdominal discomfort: stomach cramps or mild pain reported by some patients. - Diarrhea: loose stools that are generally self‑limiting. Serious or Rare Side Effects: - Anaphylaxis: a severe allergic reaction that can cause breathing difficulty, swelling and shock. - Iodide‑induced hyperthyroidism: excessive thyroid hormone production leading to symptoms such as rapid heartbeat and weight loss. - Stevens‑Johnson syndrome: a rare, severe skin reaction characterized by blistering and detachment of the epidermis.

When using Potassium Iodide, several precautions should be observed to ensure safety and effectiveness. - Assess iodine status: evaluate baseline iodine levels and dietary intake before initiating therapy to determine need. - Avoid in known hypersensitivity: do not administer to patients with a documented allergy to iodide or related compounds. - Use cautiously in thyroid disorders: monitor patients with existing hyperthyroidism or hypothyroidism closely for changes. - Monitor thyroid function: perform periodic thyroid function tests during prolonged use to detect any dysfunction early. - Store at room temperature: keep in the original container, protect from moisture and light, and avoid exposure to extreme temperatures.

Potassium Iodide can interact with several medications, requiring attention to avoid reduced efficacy or increased risk. Major Interactions (Avoid): - Levothyroxine therapy: may diminish the effectiveness of thyroid hormone replacement. - Amiodarone: combined iodine load can exacerbate thyroid dysfunction. - Lithium: concurrent use may alter thyroid hormone balance. Moderate Interactions (Monitor Closely): - ACE inhibitors: increased risk of hyperkalemia when combined with potassium‑containing agents. - Potassium‑sparing diuretics: monitor serum potassium levels to prevent excess. - Radioactive iodine therapy: timing must be coordinated to ensure optimal thyroid blocking.